A Pilot Clinical and Experimental Study of Type I Collagen Matrix Implantation Versus Microfracture for Knee Cartilage Defects.
Wei Zhu, Rongzhen Lin, Jinxi An et al.
✦ AI-curated · Sources linked
In 30 seconds
This prospective, randomized, exploratory pilot translational study compared Type I collagen matrix implantation with microfracture for knee cartilage defects, combining rat experiments with a randomized, single-blind clinical trial of 36 patients followed for 12 months. In patients, both groups improved, while the collagen group had consistently higher functional and MOCART scores (P<0.05). In rats, collagen implantation produced better cartilage and subchondral bone repair than microfracture and control. The findings suggest more favorable short-term repair and clinical outcomes with collagen implantation, but the clinical evidence comes from a small pilot study.
Key findings
- The randomized clinical trial enrolled 36 patients: 20 received collagen implantation and 16 underwent microfracture.
- Both clinical groups improved; the collagen group consistently had higher functional and MOCART scores (P<0.05).
- In rats, collagen implantation produced superior cartilage and subchondral bone repair compared with microfracture and control.
Why it matters
Cartilage repair procedures may differ in both tissue regeneration and patient-reported or imaging-based outcomes. This study provides preliminary comparative evidence that a Type I collagen matrix may improve short-term repair outcomes relative to microfracture, while its combined animal and clinical design offers supportive biological findings. The results add to a limited evidence base but do not establish longer-term comparative benefit.
What to keep in mind
The clinical trial was an exploratory pilot with 36 patients and 12 months of follow-up, limiting the strength and duration of conclusions.